GB2168969B - 1,4-dihydro pyridines - Google Patents

1,4-dihydro pyridines

Info

Publication number
GB2168969B
GB2168969B GB08520485A GB8520485A GB2168969B GB 2168969 B GB2168969 B GB 2168969B GB 08520485 A GB08520485 A GB 08520485A GB 8520485 A GB8520485 A GB 8520485A GB 2168969 B GB2168969 B GB 2168969B
Authority
GB
United Kingdom
Prior art keywords
pyridines
dihydro
dihydro pyridines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08520485A
Other languages
English (en)
Other versions
GB2168969A (en
GB8520485D0 (en
Inventor
John Leheup Archibald
Terence James Ward
Albert Opalko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John Wyeth and Brother Ltd
Original Assignee
John Wyeth and Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848421039A external-priority patent/GB8421039D0/en
Priority claimed from GB858515751A external-priority patent/GB8515751D0/en
Application filed by John Wyeth and Brother Ltd filed Critical John Wyeth and Brother Ltd
Publication of GB8520485D0 publication Critical patent/GB8520485D0/en
Publication of GB2168969A publication Critical patent/GB2168969A/en
Application granted granted Critical
Publication of GB2168969B publication Critical patent/GB2168969B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
GB08520485A 1984-08-17 1985-08-15 1,4-dihydro pyridines Expired GB2168969B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848421039A GB8421039D0 (en) 1984-08-17 1984-08-17 Heterocyclic compounds
GB858515751A GB8515751D0 (en) 1985-06-21 1985-06-21 Heterocyclic compounds

Publications (3)

Publication Number Publication Date
GB8520485D0 GB8520485D0 (en) 1985-09-18
GB2168969A GB2168969A (en) 1986-07-02
GB2168969B true GB2168969B (en) 1987-09-03

Family

ID=26288137

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08520485A Expired GB2168969B (en) 1984-08-17 1985-08-15 1,4-dihydro pyridines

Country Status (23)

Country Link
US (1) US5068337A (US20080005853A1-20080110-C00027.png)
EP (1) EP0172029B1 (US20080005853A1-20080110-C00027.png)
JP (1) JPH0680053B2 (US20080005853A1-20080110-C00027.png)
KR (1) KR930000167B1 (US20080005853A1-20080110-C00027.png)
AR (1) AR241417A1 (US20080005853A1-20080110-C00027.png)
AT (1) ATE61055T1 (US20080005853A1-20080110-C00027.png)
AU (1) AU587388B2 (US20080005853A1-20080110-C00027.png)
CA (1) CA1310011C (US20080005853A1-20080110-C00027.png)
CZ (1) CZ279473B6 (US20080005853A1-20080110-C00027.png)
DE (1) DE3581858D1 (US20080005853A1-20080110-C00027.png)
DK (1) DK374185A (US20080005853A1-20080110-C00027.png)
ES (1) ES8604564A1 (US20080005853A1-20080110-C00027.png)
FI (1) FI89166C (US20080005853A1-20080110-C00027.png)
GB (1) GB2168969B (US20080005853A1-20080110-C00027.png)
GR (1) GR851819B (US20080005853A1-20080110-C00027.png)
HU (1) HU194868B (US20080005853A1-20080110-C00027.png)
IE (1) IE58706B1 (US20080005853A1-20080110-C00027.png)
IL (1) IL75943A (US20080005853A1-20080110-C00027.png)
MY (1) MY101736A (US20080005853A1-20080110-C00027.png)
NZ (1) NZ212956A (US20080005853A1-20080110-C00027.png)
PH (1) PH26049A (US20080005853A1-20080110-C00027.png)
PT (1) PT80956B (US20080005853A1-20080110-C00027.png)
SU (1) SU1486059A3 (US20080005853A1-20080110-C00027.png)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1267416A (en) * 1985-06-17 1990-04-03 Ila Sircar 1,4-dihydropyridine derivatives useful for the treatment of cardiovascular disorders
IT1204421B (it) * 1986-06-27 1989-03-01 Boehringer Biochemia Srl 2-(aminoalchiltio)metil-1,4-diidropiridine,un metodo per la loro preparazione e composizioni farmaceutiche che le contengono
EP0225175A3 (en) * 1985-11-28 1988-12-28 FISONS plc Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof
GB8602518D0 (en) * 1986-02-01 1986-03-05 Wyeth John & Brother Ltd 1 4-dihydropyridines
DE3617976A1 (de) * 1986-05-28 1988-01-14 Alter Sa 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
FR2602231B1 (fr) * 1986-08-04 1988-10-28 Adir Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US5075324A (en) * 1986-12-24 1991-12-24 Boehringer Biochemia Robin S.P.A. Aralkyl-1,4-dihydropyridines, a method for their preparation and pharmaceutical composition containing them
GB8729471D0 (en) * 1987-12-17 1988-02-03 Wyeth John & Brother Ltd New crystal form
JPH0286981A (ja) * 1988-09-22 1990-03-27 Aisin Seiki Co Ltd ロータリ圧縮機
US5616591A (en) * 1992-03-27 1997-04-01 E.R. Squibb & Sons, Inc. Indole- and benzimidazole-substituted quinoline derivatives
DE4233601A1 (de) * 1992-10-06 1994-04-07 Bayer Ag 3-substituierte Chinolin-5-carbonsäuren
DE69423436T2 (de) * 1993-06-25 2000-09-07 Smithkline Beecham P.L.C., Brentford An lipoprotein gebundene phospholipase a2, inhibitoren davon und deren verwendung für diagnose und therapie
LV12200B (lv) * 1997-07-03 1999-04-20 Gunārs DUBURS Antidiabētisks līdzeklis
BR0116557A (pt) * 2000-12-29 2003-10-28 Pfizer Ltd Processo, processo para fabricação de um sal de maleato de amlodipina substancialmente livre de aspartato de amlodipina, processo para purificação, maleato de amlodipina, composição farmacêutica para tratar ou prevenir angina ou hipertenção, método para tratar hipertenção, angina ou ataque cardìaco, benzeno sulfonato de amlodipina, hidrocloreto de amlodipina e uso de maleato de amlodipina substancialmente livre de aspartato de amlodipina
DOP2002000328A (es) * 2001-02-14 2003-08-30 Warner Lambert Co Pirimidinas inhibidoras de metaloproteinasas de matriz
US6566359B1 (en) 2002-05-20 2003-05-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College 2,4,6-trimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid esters as neuroprotective drugs

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
DE2639257A1 (de) * 1976-09-01 1978-03-02 Bayer Ag Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2658183A1 (de) * 1976-12-22 1978-07-06 Bayer Ag In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4177278A (en) * 1977-04-05 1979-12-04 Bayer Aktiengesellschaft 2-Alkyleneaminodihydropyridines compounds, their production and their medicinal use
DE2738153A1 (de) * 1977-08-24 1979-03-08 Bayer Ag 2-pyridyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
JPS5547656A (en) * 1978-09-29 1980-04-04 Dainippon Pharmaceut Co Ltd 2-(2-substituted aminoethyl)-1,4-dihydropyridine derivative and its derivative
DE2844595A1 (de) * 1978-10-13 1980-04-30 Bayer Ag Acylaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
SE8105230L (sv) * 1981-09-03 1983-03-04 Haessle Ab Nya dihydropyridiner
EP0080220B1 (en) * 1981-11-17 1986-02-19 FISONS plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
WO1983003249A1 (en) * 1982-03-17 1983-09-29 Yoshitomi Pharmaceutical 1,4-dihydropyridine-3,5-dicarboxylate derivatives
DE3363743D1 (en) * 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
PT77842B (en) * 1982-12-21 1986-05-05 Pfizer Process for preparing dihydropyridines
US4515799A (en) * 1983-02-02 1985-05-07 Pfizer Inc. Dihydropyridine anti-ischaemic and antihypertensive agents
EP0125803A3 (en) * 1983-04-27 1987-01-21 FISONS plc Pharmaceutically active dihydropyridines
US4568677A (en) * 1983-07-23 1986-02-04 Pfizer Inc. 2-(4-Pyrimidone alkoxyalkyl) dihydropyridine anti-ischaemic and antihypertensive agents
GB8414518D0 (en) * 1984-06-07 1984-07-11 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
EP0172029A1 (en) 1986-02-19
US5068337A (en) 1991-11-26
CZ279473B6 (cs) 1995-05-17
KR870002122A (ko) 1987-03-30
CA1310011C (en) 1992-11-10
AR241417A1 (es) 1992-07-31
IL75943A0 (en) 1985-12-31
FI853103L (fi) 1986-02-18
PT80956A (en) 1985-09-01
AU587388B2 (en) 1989-08-17
DK374185D0 (da) 1985-08-16
IE58706B1 (en) 1993-11-03
PT80956B (pt) 1987-12-30
HU194868B (en) 1988-03-28
ES546189A0 (es) 1986-02-01
GR851819B (US20080005853A1-20080110-C00027.png) 1985-11-26
ES8604564A1 (es) 1986-02-01
IL75943A (en) 1988-12-30
DE3581858D1 (en) 1991-04-04
ATE61055T1 (de) 1991-03-15
KR930000167B1 (ko) 1993-01-11
IE851860L (en) 1986-02-17
FI853103A0 (fi) 1985-08-13
JPH0680053B2 (ja) 1994-10-12
FI89166B (fi) 1993-05-14
HUT40106A (en) 1986-11-28
EP0172029B1 (en) 1991-02-27
GB2168969A (en) 1986-07-02
SU1486059A3 (ru) 1989-06-07
GB8520485D0 (en) 1985-09-18
MY101736A (en) 1992-01-17
DK374185A (da) 1986-02-18
PH26049A (en) 1992-01-29
CZ592285A3 (en) 1995-02-15
JPS6157578A (ja) 1986-03-24
NZ212956A (en) 1988-09-29
FI89166C (fi) 1993-08-25
AU4572685A (en) 1986-02-20

Similar Documents

Publication Publication Date Title
GB2153821B (en) 3-imidazolylmethyl-1,2,3,9-tetrahydro-4h-carbazol-4-one derivatives
CY1494A (en) 4-aryl-1,-4-dihydropyridine-3,5-dicaboxylate derivatives
HK92587A (en) Furo-(3,4-c)-pyridine derivatives
IL76955A0 (en) 2,6-substituted pyridine compounds
GB2168969B (en) 1,4-dihydro pyridines
CS78585A2 (en) Zpusob vyroby 1,3 disubstituovanych 2 oxindolu
AU556636B2 (en) 1,4-dihydro pyridines
EP0183975A3 (en) 5,6,7,8-tetrafluoroanthraquinone derivatives
GB2166136B (en) Furo-(3,4-c)-pyridine derivatives
GB2162175B (en) 1,8-diacyloxy-10-acylanthrones
HK185395A (en) 9,11-Epoxy-21-hydroxypregnane derivatives
GB2167745B (en) 1,4-dihydropyridines
ZA851949B (en) 1,2,4-triazacycloalkadiene derivatives
IL74372A0 (en) 2-arylimidazo(4,5-c)pyridines
AU1464583A (en) 2,6-dialkyl-4-phenyl-3,5-diester-1,4-dihydro pyridines
GB2164037B (en) 6-aminomethyl-furo-(3,4-c)-pyridine derivatives
AR242956A1 (es) Procedimiento para la preparacion de derivados de 2-fenilpirano(2,3-b)-piridinas.
GB2153824B (en) Furo-(3,4-c)-pyridine derivatives
GB2156353B (en) 6,6-ethylenedioxy-22r-hydroxy-2r,3s-isopropylidenedioxy-5a-cholest-23-yne
GB8530178D0 (en) 1,4-dihydropyridine derivatives
CS320285A2 (en) Zpusob vyroby n,3 disubstituovanych 2 oxindol 1 karboxamidu
GB8523735D0 (en) 1,2-benzoxathiine derivatives
CS219684A1 (en) Sposob pripravy 1 2,6 dimetylfenoxy 2 propylaminu
ZA857123B (en) Substituted 1,1-bis-azolyl-butan-2-ones and-ols
EP0170822A3 (en) 2,3-dihydrobenzo-4-oxa-thiine

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19990815